APA (7th ed.) Citation

JJ, C., AD, S., AF, L., MS, E., AM, N., HJ, H., . . . M, D. (2016). Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature communications, 7, 13513. https://doi.org/10.1038/ncomms13513

Chicago Style (17th ed.) Citation

JJ, Chabon, et al. "Corrigendum: Circulating Tumour DNA Profiling Reveals Heterogeneity of EGFR Inhibitor Resistance Mechanisms in Lung Cancer Patients." Nature Communications 7 (2016): 13513. https://doi.org/10.1038/ncomms13513.

MLA (9th ed.) Citation

JJ, Chabon, et al. "Corrigendum: Circulating Tumour DNA Profiling Reveals Heterogeneity of EGFR Inhibitor Resistance Mechanisms in Lung Cancer Patients." Nature Communications, vol. 7, 2016, p. 13513, https://doi.org/10.1038/ncomms13513.